ArticleAJNR. American journal of neuroradiology2025
Safety and Efficacy of Combined Venous Sinus Balloon Protection Technique in Transarterial Embolization of Low- and Intermediate-Grade Transverse-Sigmoid Sinus Dural Arteriovenous Fistulas: A Cohort of 161 Patients.
Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades.Stroke and vascular neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeThe venous sinus balloon protection technique is regarded as a safe and effective method for treating transverse-sigmoid sinus (TSS) dural arteriovenous fistulas (DAVFs). However, large cohort studies on this technology are still lacking. This study aims to present a large single-center experience on the safety and efficacy of venous sinus balloon protection (VSBP) in the treatment of TSS DAVFs. MATERIALS AND
methodsWe conducted a retrospective review of our database, identifying all patients with low- and intermediate-grade TSS-DAVFs who underwent transarterial embolization between 2000 and 2020. The patients were categorized into 2 groups: the VSBP group and the non-venous sinus balloon protection (NVSBP) group, based on the use of the VSBP technique. The safety and efficacy of the venous sinus balloon protection technique were subsequently analyzed.
resultsThe study included 161 patients with low- and intermediate-grade TSS-DAVFs who received transarterial embolization, comprising 72 individuals in the VSBP group and 89 in the NVSBP group. The objective of the study was to evaluate the safety and efficacy of sinus balloon protection by comparing clinical and angiographic outcomes, as well as complication rates, between the 2 groups. Favorable clinical outcomes were similar between the 2 groups (VSBP 93.1% versus NVSBP 96.6%,
conclusionsThe sinus balloon protection technique demonstrates excellent safety and effectiveness, significantly improving the complete occlusion rate of low- and intermediate-grade TSS-DAVFs in the near term, without increasing the incidence of complications. In the future, larger prospective cohorts are needed to further elucidate and confirm the safety and effectiveness of the sinus balloon protection technique for all dural arteriovenous fistulas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.